Culture medium and method for soluble expression of high-enzyme-activity halophilic organism-derived protein
By adjusting the ion species and osmotic pressure in the culture medium, the soluble expression and enzyme activity of halophilic microbial enzymes are improved, and the problem of low soluble expression of halophilic microbial enzymes in fermentation production is solved, achieving high enzyme activity and industrial Application potential.
Patent Information
- Application Number
- CN202411398121.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-09
- Publication Date
- 2024-12-06
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Enzymes from halophilic microbial origin are not highly soluble in fermentation production and are difficult to maintain high enzyme activity. The prior art lacks systematic solutions.
By adjusting the ion species and concentration in the culture medium, increase the osmotic pressure in the solution, especially using hypertonic media such as NaCl, KCl, MgCl2, NaH2PO4 and sorbitol, the culture medium is optimized to improve the soluble expression of halophilic microbial enzymes, and Maintain enzyme activity.
It significantly improves the soluble expression of halophilic microbial enzymes and maintains high enzyme activity. Compared with traditional LB culture medium, the high-salt or hypertonic culture medium provided significantly improves 7α-hydroxysteroid dehydrogenase 7A-4 soluble expression and enzyme activity have good industrial application potential.
Smart Images

Figure CN119081980A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of bioengineering, and particularly relates to a culture medium for soluble expression of a protein from a halophilic organism with high enzyme activity, and a method for soluble expression of a protein from a halophilic organism with high enzyme activity by using the culture medium. Background Art
[0002] Protein plays an important role in many fields including food, medicine and chemical industry, and protein synthesis is a big industry. Due to species differences, high-yield requirements and reduced production costs, heterologous expression often leads to insolubility and low enzyme activity of product proteins under the conditions of expression amount, expression environment and protein source, which is also a big problem faced by the protein synthesis industry. Some methods are used in industry to improve the solubility of expressed proteins, such as controlling the expression rate, using molecular chaperones and fusion tags, but these methods are universal. Due to the particularity of protein sources, such as halophilic proteins, thermophilic proteins, acidophilic proteins or alkaliphilic proteins, they have some protein specificity. Especially when using enzymes from these extreme sources, the expression of soluble and high enzyme activity is still a challenge.
[0003] There is currently no systematic research mechanism for enzymes derived from halophilic microorganisms. We have vast marine resources and a large number of enzymes derived from halophilic microorganisms. However, there are very limited reports on the soluble expression of these enzymes at home and abroad, and related research has not been carried out in depth. Therefore, we designed a method to improve the soluble expression and maintain high enzyme activity of enzymes derived from halophilic microorganisms. Summary of the invention
[0004] In order to solve the problem of low soluble expression of enzymes derived from halophilic microorganisms in fermentation production in the prior art, the present invention provides a culture medium for soluble expression of high enzyme activity halophilic biological source protein, and a method for soluble expression of high enzyme activity halophilic biological source protein by the culture medium. Specifically, the soluble expression of protein by halophilic microorganisms is further improved by changing the ion types in the culture medium and increasing the osmotic pressure in the solution, while at the same time making the expressed protein still maintain a high enzyme activity.
[0005] The technical solution adopted by the present invention is: a culture medium for soluble expression of high enzyme activity halophilic biological source protein, the culture medium comprising: tryptone, yeast extract, hypertonic medium, antibiotics, water; the hypertonic medium is selected from at least one of NaCl, KCl, MgCl2, NaH2PO4, and sorbitol, preferably any one of NaCl, KCl, MgCl2, NaH2PO4, and sorbitol, and more preferably any one of NaCl, NaH2PO4, and sorbitol.
[0006] Preferably, the protein is 7α-hydroxysteroid dehydrogenase 7A-4 from Halomonasjeotgali, and its amino acid sequence is preferably as shown in SEQ ID NO.2, and its nucleotide sequence is preferably as shown in SEQ ID NO.1.
[0007] In order to improve the soluble expression of 7α-hydroxysteroid dehydrogenase 7A-4 from halophilic microorganism Halomonasjeotgali by host cell Escherichia coli, the present invention attempts to improve the culture medium used for host cell fermentation culture in a targeted manner, specifically by changing the ion type and concentration in the culture medium and increasing the osmotic pressure in the solution to improve the soluble expression of 7A-4 from halophilic microorganisms, and the expressed 7A-4 still maintains a high enzyme activity. In some specific embodiments, the present invention obtains a high salt or hypertonic culture medium that can improve the soluble expression of 7A-4 from halophilic microorganisms by changing the NaCl concentration, KCl concentration, MgCl2 concentration, NaH2PO4 concentration or sorbitol concentration in the culture medium; at the same time, compared with the traditional LB culture medium (NaCl concentration 10g / L), the 7α-hydroxysteroid dehydrogenase 7A-4 expressed by the culture medium provided by the present invention still has good enzyme activity, which better solves the problem of inclusion bodies and has good industrial application potential.
[0008] Preferably, the NaCl concentration in the culture medium is 20-40 g / L, more preferably 20-30 g / L, and further preferably 20 g / L. Experiments have shown that compared with traditional LB culture medium, when the NaCl concentration in the culture medium provided by the present invention is adjusted to 20-30 g / L, the soluble expression of 7A-4 is greatly improved, and the higher NaCl concentration does not have a substantial effect on the enzyme activity of 7A-4.
[0009] The present invention further explored the effect of changes in ion species (NaCl, KCl, MgCl2, NaH2PO4) in the culture medium on the soluble expression of 7A-4. - , Na + It had a greater effect on the soluble expression of 7A-4.
[0010] Preferably, the KCl concentration in the culture medium is 10 to 30 g / L, more preferably 10 to 20 g / L, and further preferably 20 g / L.
[0011] Preferably, the concentration of MgCl2 in the culture medium is 1-10 g / L.
[0012] Preferably, the concentration of NaH2PO4 in the culture medium is 10 to 30 g / L, more preferably 20 to 30 g / L, and further preferably 30 g / L.
[0013] The present invention further explores the effect of changes in the osmotic pressure of the culture medium on the soluble expression of 7A-4. Specifically, sorbitol, which has good biocompatibility and low toxicity, is used as an osmotic regulator. By increasing the concentration of sorbitol, a high osmotic pressure environment is effectively simulated, thereby studying the soluble expression of 7A-4 under hypertonic conditions. The experiment found that compared with the traditional LB culture medium, when the sorbitol concentration in the culture medium provided by the present invention is adjusted to 20-30 g / L, appropriate high osmotic pressure can also significantly improve the soluble expression of 7A-4.
[0014] Preferably, the sorbitol concentration in the culture medium is 10 to 30 g / L, more preferably 20 to 30 g / L, and even more preferably 30 g / L.
[0015] Preferably, the trypsin concentration in the culture medium is 8-12 g / L, and the yeast extract concentration is 4-6 g / L.
[0016] Preferably, the antibiotic concentration in the culture medium is 40-60 mg / L; the antibiotic is selected from one or both of ampicillin and kanamycin.
[0017] Preferably, the pH value of the culture medium is 7.0-7.5.
[0018] Preferably, the culture medium comprises: 8-12 g / L tryptone, 4-6 g / L yeast extract, 20-40 g / L NaCl, 40-60 mg / L ampicillin, and water.
[0019] Preferably, the culture medium comprises: 8-12 g / L tryptone, 4-6 g / L yeast extract, 10-30 g / L NaH2PO4, 40-60 mg / L ampicillin, and water.
[0020] Preferably, the culture medium comprises: 8-12 g / L tryptone, 4-6 g / L yeast extract, 10-30 g / L sorbitol, 40-60 mg / L ampicillin, and water.
[0021] The present invention also provides the use of the culture medium in the preparation of 7α-hydroxysteroid dehydrogenase 7A-4 by biological fermentation. Specifically, the method of the use comprises: inoculating a genetically engineered bacterium containing a gene encoding 7α-hydroxysteroid dehydrogenase into the culture medium for fermentation culture to obtain 7α-hydroxysteroid dehydrogenase.
[0022] The present invention also provides a method for soluble expression of high enzyme activity halophilic biological source protein, the method comprising: inoculating a genetically engineered bacterium containing a Halomonasjeotgali-derived 7α-hydroxysteroid dehydrogenase 7A-4 encoding gene into the culture medium for fermentation culture to obtain 7α-hydroxysteroid dehydrogenase.
[0023] Preferably, the method for constructing the genetically engineered bacteria comprises: connecting the coding gene of 7α-hydroxysteroid dehydrogenase 7A-4, whose nucleotide sequence is shown in SEQ ID NO.1, to an expression vector, and then transferring the expression vector into Escherichia coli to construct the genetically engineered bacteria. The expression vector is preferably pET22b, and the Escherichia coli is preferably Escherichia coli BL21 (DE3).
[0024] Preferably, the culture method comprises: culturing the genetically engineered bacteria to obtain a seed solution, inoculating the seed solution into a fermentation system at an inoculation rate of 2% to 3% (v / v), culturing at 35 to 40°C and 150 to 200rpm until OD600 is 0.6 to 0.8, adding an inducer IPTG with a final concentration of 0.20mM, and inducing the culture at 25 to 30°C and 150 to 200rpm for 10 to 15h.
[0025] Beneficial effects of the present invention: Starting from the fermentation system, the present invention improves the soluble expression of 7α-hydroxysteroid dehydrogenase 7A-4 from the halophilic microorganism Halomonasjeotgali by changing the ion type and concentration in the culture medium and increasing the osmotic pressure in the solution, and the expressed 7A-4 still maintains a high enzyme activity. Compared with the traditional LB culture medium (NaCl concentration 10g / L), the high salt or hypertonic culture medium provided by the present invention has a greatly improved soluble expression of 7α-hydroxysteroid dehydrogenase 7A-4, and maintains a good enzyme activity, effectively solving the problem of inclusion bodies, and has good industrial application potential. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 This is an SDS-PAGE image of the expression of 7α-hydroxysteroid dehydrogenase 7A-4 when the NaCl concentration in the culture medium is changed in Example 1; Lane S represents the enzyme content in the supernatant; Lane P represents the enzyme content in the precipitate.
[0027] Figure 2 The enzyme activity of 7α-hydroxysteroid dehydrogenase 7A-4 when the NaCl concentration in the culture medium was changed in Example 1.
[0028] Figure 3The SDS-PAGE diagram of 7α-hydroxysteroid dehydrogenase 7A-4 expression when the type and concentration of the hypertonic medium in the culture medium were changed in Example 2 and Example 3; Lane S represents the enzyme content in the supernatant; Lane P represents the enzyme content in the precipitate; C: LB control group; So: sorbitol. DETAILED DESCRIPTION
[0029] The following is an explanation of the embodiments of the present invention by specific specific examples, and those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. The present invention can also be implemented or applied by other different specific embodiments, and the details in this specification can also be modified or changed in various ways based on different viewpoints and applications without departing from the spirit of the present invention. It should be noted that, in the absence of conflict, the features in the following embodiments and embodiments can be combined with each other. In the embodiments of the present invention, the methods used are all conventional methods unless otherwise specified, and the reagents used can be obtained from commercial sources.
[0030] Example 1: Effects of different NaCl concentrations in the culture medium on soluble expression and enzyme activity of 7A-4
[0031] Example 1 provides the following three culture media for soluble expression of high enzyme activity halophilic biological source protein (abbreviated as culture medium 1-1, culture medium 1-2, culture medium 1-3):
[0032] Medium 1-1: tryptone 10 g / L, yeast extract 5 g / L, NaCl 20 g / L, ampicillin 50 mg / L, solvent is pure water, pH 7.0;
[0033] Medium 1-2: tryptone 10 g / L, yeast extract 5 g / L, NaCl 30 g / L, ampicillin 50 mg / L, solvent is pure water, pH 7.0;
[0034] Culture medium 1-3: tryptone 10 g / L, yeast extract 5 g / L, NaCl 40 g / L, ampicillin 50 mg / L, solvent is pure water, pH 7.0.
[0035] In addition, the following two culture media were used as comparisons in this example:
[0036] Salt-free culture medium: tryptone 10 g / L, yeast extract 5 g / L, ampicillin 50 mg / L, solvent is pure water, pH 7.0;
[0037] LB medium: tryptone 10 g / L, yeast extract 5 g / L, NaCl 10 g / L, ampicillin 50 mg / L, solvent is pure water, pH 7.0.
[0038] As another implementation of this example, this example also applies the above-mentioned culture media 1 to 3, salt-free culture medium and LB culture medium to prepare 7α-hydroxysteroid dehydrogenase 7A-4 by biological fermentation.
[0039] As another implementation of this example, this example also provides a method for soluble expression of a protein from a halophilic organism with high enzyme activity, as follows.
[0040] Construction of expression vector:
[0041] The 7A-4 gene from Halomonasjeotgali (Gene Bank: WP_0174303001, full protein sequence see SEQ ID NO.2) was optimized according to the usage of Escherichia coli codons and chemically synthesized by Hangzhou Qingke Biotechnology Co., Ltd., and its nucleotide sequence is shown in SEQ ID NO.1.
[0042] The 7A-4 gene was double-digested with Nde I and EcoR I (Thermo Fisher Scientific) and purified using a purification kit (Beijing Qingke Biotechnology Co., Ltd.) to obtain a 7A-4 gene fragment; the plasmid pET22b was double-digested with Nde I and EcoR I (Thermo Fisher Scientific) and recovered by nucleic acid gel to obtain a linear plasmid fragment. The obtained 7A-4 gene fragment was connected to the linear plasmid fragment.
[0043] T4 ligation system: 4 μL 7A-4 gene fragment, 4 μL pET22b plasmid fragment, 1 μL T4 ligase, 1 μL T4 ligase buffer, ligation at 16°C overnight.
[0044] The ligation product was transformed into Escherichia coli DH5α competent cells, then spread on LB solid medium containing ampicillin (50 μg / mL), cultured at 37°C for 10 h, and transformants were selected and sequenced to finally obtain the correct transformant, namely E. coli DH5α / pET22b-7A-4.
[0045] Construction of genetically engineered bacteria:
[0046] Take 2-5 μL of recombinant plasmid pET22b-7A-4, add E. coli BL21 (DE3) competent cells, incubate on ice for 30 min, then heat shock at 42°C for 90 s, add 800 μL LB for recovery for 40 min, spread on LB solid culture medium containing ampicillin (50 μg / mL), culture at 37°C for 12 h, select the correct transformant to LB liquid culture medium, culture at 37°C, 180 rpm, after 10 h, add glycerol, preserve the strain at -80°C, which is the genetically engineered strain E. coli BL21 (DE3) / pET22b-7A-4 used for fermentation.
[0047] Expression and purification:
[0048] (1) Seed activation stage
[0049] Take 10 μL of the constructed genetically engineered bacteria from the -80°C glycerol tube and inoculate it into a 100 mL Erlenmeyer flask containing 10 mL of liquid LB medium. Use a rotary constant temperature and speed control shaker for culture, control the temperature at 37°C, the speed at 180 rpm, the initial pH at 7.0, and culture for 12 h.
[0050] (2) Shake flask fermentation stage
[0051] Shake flask culture and induced protein expression: The cultured seed solution was transferred to 100 mL of the above-mentioned culture medium (culture medium 1-1, culture medium 1-2, culture medium 1-3, salt-free culture medium, LB culture medium) sterilized in advance at a volume fraction of 2% (v / v). After culturing in a constant temperature shaker at 37°C and 180rpm until OD600 is 0.6-0.8, add the inducer IPTG with a final concentration of 0.20mM, and induce the culture at 28°C and 180rpm for 12h. All 7A-4 proteins were expressed in E.coli BL21 (DE3) cells and had a c-terminal His6 tag for easy purification.
[0052] (3) Protein purification stage
[0053] Cells were disrupted using a cell disruptor and then centrifuged at 8000 rpm for 10 minutes at 4 °C. The resulting supernatant was then analyzed by SDS-PAGE to assess protein expression levels. For purification, the protein in the supernatant was first balanced with a buffer solution (100 mm potassium phosphate buffer). The Ni-IDA column was then filled for purification to ensure effective separation of the target protein. The purity of the extracted protein was subsequently assessed using the SDS-PAGE gel method.
[0054] (4) Enzyme activity assay
[0055] 7-KLCA was determined by high performance liquid chromatography (HPLC, Thermo SCIENTIFIC, DIONEX UltiMate 3000) to quantitatively determine the enzyme activity of 7A-4 and its variants in CDCA oxidation at 30°C. The unit of enzyme activity is defined as the amount of 7-KLCA produced in 1 minute at 30°C, and the unit of measurement is micromolar (mM). The specific steps refer to Chinese patent CN117448291A.
[0056] Example 2: Effects of different ion species and concentrations in the culture medium on the soluble expression of 7A-4
[0057] Example 2 provides the following three types of culture media for soluble expression of high enzyme activity halophilic biological source protein:
[0058] Medium 2-1: tryptone 10 g / L, yeast extract 5 g / L, KCl 10 g / L, ampicillin 50 mg / L, solvent is pure water, pH 7.0;
[0059] Medium 2-2: tryptone 10 g / L, yeast extract 5 g / L, KCl 20 g / L, ampicillin 50 mg / L, solvent is pure water, pH 7.0;
[0060] Culture medium 2-3: 10 g / L tryptone, 5 g / L yeast extract, 30 g / L KCl, 50 mg / L ampicillin, solvent is pure water, pH 7.0.
[0061] Medium 3-1: tryptone 10 g / L, yeast extract 5 g / L, NaH2PO4 10 g / L, ampicillin 50 mg / L, solvent is pure water, pH 7.0;
[0062] Medium 3-2: tryptone 10 g / L, yeast extract 5 g / L, NaH2PO4 20 g / L, ampicillin 50 mg / L, solvent is pure water, pH 7.0;
[0063] Culture medium 3-3: tryptone 10 g / L, yeast extract 5 g / L, NaH2PO4 30 g / L, ampicillin 50 mg / L, solvent is pure water, pH 7.0.
[0064] Culture medium 4: tryptone 10 g / L, yeast extract 5 g / L, MgCl2 10 g / L, ampicillin 50 mg / L, solvent is pure water, pH 7.0.
[0065] As another implementation of this example, this example also applies the above-mentioned culture media 2-1 to 2-3, culture media 3-1 to 3-3, and culture media 4 to prepare 7α-hydroxysteroid dehydrogenase 7A-4 by biological fermentation.
[0066] As another embodiment of this embodiment, this embodiment also provides a method for soluble expression of high enzyme activity halophilic biological source protein. Compared with Example 1, the difference is that the above-mentioned culture medium 2-1 to 2-3, culture medium 3-1 to 3-3, and culture medium 4 are respectively used for shake flask fermentation of genetically engineered bacteria, and the remaining steps are the same as Example 1.
[0067] Example 3: Effect of different osmotic pressures in the culture medium on the soluble expression of 7A-4
[0068] Example 3 provides the following three culture media for soluble expression of high enzyme activity halophilic biological source protein:
[0069] Medium 5-1: tryptone 10 g / L, yeast extract 5 g / L, sorbitol 10 g / L, ampicillin 50 mg / L, solvent is pure water, pH 7.0;
[0070] Medium 5-2: tryptone 10 g / L, yeast extract 5 g / L, sorbitol 20 g / L, ampicillin 50 mg / L, solvent is pure water, pH 7.0;
[0071] Culture medium 5-3: 10 g / L tryptone, 5 g / L yeast extract, 30 g / L sorbitol, 50 mg / L ampicillin, solvent is pure water, pH 7.0.
[0072] As another implementation of this example, this example also applies the above-mentioned culture media 5-1 to 5-3 to prepare 7α-hydroxysteroid dehydrogenase 7A-4 by biological fermentation.
[0073] As another embodiment of this example, this example also provides a method for soluble expression of high enzyme activity halophilic biological source protein. Compared with Example 1, the difference is that the above-mentioned culture medium 5-1 to 5-3 are respectively used for shake flask fermentation of genetically engineered bacteria, and the remaining steps are the same as Example 1.
[0074]
Result Analysis
[0075] Effects of different NaCl concentrations on soluble expression of 7A-4 Figure 1As shown. When the NaCl concentration in the culture medium was 20 g / L, the soluble expression of 7A-4 was optimal (see lane S 7A-4 band). It is worth noting that when the NaCl concentration in the LB medium increased to 50 g / L and 60 g / L, the growth of the bacteria was inhibited, which may be due to the high salt concentration in the culture environment.
[0076] Effects of different NaCl concentrations on 7A-4 enzyme activity Figure 2 As shown. Among them, when the NaCl concentration in the culture medium is 10g / L, 7A-4 has the highest enzyme activity. It is worth noting that compared with not adding NaCl, the enzyme activity of 7A-4 is not significantly different when the NaCl concentration is in the range of 10-40g / L. Therefore, changing the NaCl concentration in the culture medium (20-40g / L) can not only improve the soluble expression of 7A-4, but also the higher NaCl concentration will not have a substantial effect on the activity of the enzyme.
[0077] Effects of different ion types, concentrations and osmotic pressures on the soluble expression of 7A-4 Figure 3 The results show that relative to Cl - , Na + It has a greater impact on the soluble expression of 7A-4. Furthermore, the experiment also found that adding an appropriate concentration of NaH2PO4 (30g / L) to the culture medium can significantly improve the soluble expression of 7A-4. The present invention also further explores the effect of changes in the osmotic pressure of the culture medium on the soluble expression of 7A-4. The experiment found that compared with the traditional LB culture medium, when the sorbitol concentration in the culture medium provided by the present invention is adjusted to 20-30g / L, the appropriate high osmotic pressure can also significantly improve the soluble expression of 7A-4.
[0078] The embodiments described above are merely descriptions of preferred implementations of the present invention and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope of the present invention.
Claims
1. A culture medium for soluble expression of high enzyme activity halophilic biological source protein, characterized in that: The culture medium comprises: tryptone, yeast extract, hypertonic medium, and water; The hypertonic medium is selected from at least one of NaCl, KCl, MgCl2, NaH2PO4, and sorbitol.
2. The culture medium according to claim 1, characterized in that The protein is 7α-hydroxysteroid dehydrogenase 7A-4 derived from Halomonasjeotgali.
3. The culture medium according to claim 1, characterized in that The NaCl concentration in the culture medium is 10-40 g / L.
4. The culture medium according to claim 1, characterized in that The KCl concentration in the culture medium is 10-30 g / L.
5. The culture medium according to claim 1, characterized in that The concentration of MgCl2 in the culture medium is 1-10 g / L.
6. The culture medium according to claim 1, characterized in that The concentration of NaH2PO4 in the culture medium is 10-30 g / L.
7. The culture medium according to claim 1, characterized in that The sorbitol concentration in the culture medium is 10-30 g / L.
8. The culture medium according to claim 1, characterized in that The trypsin concentration in the culture medium is 8-12 g / L, and the yeast extract concentration is 4-6 g / L; The culture medium also includes an antibiotic with a concentration of 40-60 mg / L; the antibiotic is selected from one or both of ampicillin and kanamycin.
9. Use of the culture medium according to any one of claims 1 to 8 in the preparation of 7α-hydroxysteroid dehydrogenase 7A-4 by biological fermentation.
10. A method for soluble expression of a protein from a halophilic organism with high enzyme activity, characterized in that: The method comprises: inoculating a genetically engineered bacterium containing a gene encoding 7α-hydroxysteroid dehydrogenase 7A-4 derived from Halomonasjeotgali into a culture medium as described in any one of claims 1 to 8 for fermentation culture to obtain 7α-hydroxysteroid dehydrogenase 7A-4.
Citation Information
Patent Citations
Method for high-efficiency expression of target protein by using pichia pastoris PGAPZaA carrier
CN104195164A
Preparation method of 3alpha-hydroxyl-7-keto-5beta-cholanoate and enzyme 1 for preparation
CN107995928A
Method for producing and secreting protein by halobacteria
CN112680433A
Expression method of high-activity hydroxysteroid dehydrogenase
CN114774380A
Method of producing three kinds of human alpha alexins by gene engineering bacteria mixed culture
CN1904036A
